Ovid Therapeutics
OVID
OVID
67 hedge funds and large institutions have $109M invested in Ovid Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
Holders
67
Holding in Top 10
1
Calls
$1.2M
Puts
–
Top Buyers
| 1 | +$2.42M | |
| 2 | +$983K | |
| 3 | +$534K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$439K |
| 5 |
Bank of New York Mellon
New York
|
+$433K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$1.12M | |
| 3 | -$560K | |
| 4 |
HF
HRT Financial
New York
|
-$384K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$257K |